Postharvest blue mold in apples, caused by Penicillium expansum, leads to fruit decay and patulin (PAT) contamination, incurring major economic and health risks. This study developed a composite biocontrol agent (BCA) by co-cultivating three antagonistic yeasts (Meyerozyma caribbica, Metschnikowia zizyphicola, and Pichia rarassimilans). Mixed-culture conditions and protective additives formulation were optimized via response surface methodology. Optimal biomass production was achieved with a 1:2:3 (v/v/v) yeast ratio in medium containing sucrose (12.49 g/L), yeast extract powder (13.3 g/L), K2HPO4 (0.88 g/L), and NaCl (0.95 g/L) under pH 7.0, 1% total inoculum concentration, 24 °C, and a 60 h incubation. The liquid BCA formulation, stabilized with 0.27% gum arabic, 0.49% Tween-80, and 0.079% ascorbic acid, maintained high viability (9.15 log10 CFU/mL after 7 days). In vivo/in vitro trials all demonstrated that the composite BCA rapidly colonized, suppressed P. expansum infection, and significantly delayed pathogen spore germination and hyphal growth. Furthermore, the BCA effectively degraded 10 μg/mL PAT within 24–42 h in various fruit juices with minimal adverse effects on juice quality parameters. Storage at −20 °C preserved the highest bioactivity (7.93 × 108 CFU/mL after 5 months). This optimized composite yeast formulation provides an efficient, eco-friendly strategy for integrated apple postharvest blue mold and PAT detoxification.
Cong et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: